Zogenix (ZGNX)
Zogenix Market Cap: 117.67M
- Accounts Payable
- Accounts Receivable
- Accruals Pro
- Altman Z-Score Pro
- Asset Utilization
- Beneish M-Score Pro
- Beta Pro
- Book Value
- Book Value per Share
- Capital Expenditures
- Cash Conversion Cycle Pro
- Cash Div. Payout Ratio TTM Pro
- Cash Financing
- Cash Financing TTM
- Cash Investing
- Cash Investing TTM
- Cash Operations
- Cash Operations TTM
- Cash and Equivalents
- Cash and ST Investments
- Current Ratio
- Days Inventory Outstanding Pro
- Days Payable Outstanding Pro
- Days Sales Outstanding Pro
- Debt to Equity Ratio
- Dividend
- Dividend Yield
- EBITDA Margin TTM Pro
- EBITDA TTM Pro
- EV / EBIT Pro
- EV / EBITDA Pro
- EV / Free Cash Flow Pro
- EV / Revenues Pro
- Earnings Per Share
- Earnings Per Share Growth
- Earnings Per Share TTM
- Earnings Yield
- Effective Tax Rate TTM Pro
- Enterprise Value
- Expenses
- Expenses TTM
- Free Cash Flow
- Free Cash Flow TTM
- Free Cash Flow Yield Pro
- Fundamental Score Pro
- Gross Profit Margin
- Gross Profit TTM
- Income from Cont. Ops Pro
- Interest Expense
- Interest Income
- Inventories
- KZ Index Pro
- Liabilities
- Long Term Debt
- Market Cap
- Net Income
- Net Income TTM
- Net PP&E
- Operating Earnings Yield Pro
- Operating Margin TTM Pro
- Operating PE Ratio Pro
- Other Comprehensive Income Pro
- PE 10 Pro
- PE Ratio
- PE Value Pro
- PEG Ratio
- PS Value Pro
- Payout Ratio TTM Pro
- Price
- Price / Book Value
- Price / Sales Ratio
- Price / Tangible Book Value Pro
- Profit Margin
- R&D Expense
- Receivables Turnover
- Retained Earnings
- Retained Earnings Growth
- Return on Assets
- Return on Equity
- Return on Invested Capital Pro
- Revenue Growth
- Revenue Per Share TTM
- Revenues
- Revenues TTM
- SG&A Expense
- Shareholders Equity
- Shares Outstanding
- Stock Buybacks
- Tangible Book Value Pro
- Tangible Book Value Per Share Pro
- Tangible Common Equity Ratio Pro
- Times Interest Earned TTM Pro
- Total Assets
- Total Return Price
- Valuation (Historical Mult.) Pro
- Valuation Percentage Pro
- Value Score Pro
- Accounts Payable
- Accounts Receivable
- Accruals Pro
- Altman Z-Score Pro
- Asset Utilization
- Beneish M-Score Pro
- Beta Pro
- Book Value
- Book Value per Share
- Capital Expenditures
- Cash Conversion Cycle Pro
- Cash Div. Payout Ratio TTM Pro
- Cash Financing
- Cash Financing TTM
- Cash Investing
- Cash Investing TTM
- Cash Operations
- Cash Operations TTM
- Cash and Equivalents
- Cash and ST Investments
- Current Ratio
- Days Inventory Outstanding Pro
- Days Payable Outstanding Pro
- Days Sales Outstanding Pro
- Debt to Equity Ratio
- Dividend
- Dividend Yield
- EBITDA Margin TTM Pro
- EBITDA TTM Pro
- EV / EBIT Pro
- EV / EBITDA Pro
- EV / Free Cash Flow Pro
- EV / Revenues Pro
- Earnings Per Share
- Earnings Per Share Growth
- Earnings Per Share TTM
- Earnings Yield
- Effective Tax Rate TTM Pro
- Enterprise Value
- Expenses
- Expenses TTM
- Free Cash Flow
- Free Cash Flow TTM
- Free Cash Flow Yield Pro
- Fundamental Score Pro
- Gross Profit Margin
- Gross Profit TTM
- Income from Cont. Ops Pro
- Interest Expense
- Interest Income
- Inventories
- KZ Index Pro
- Liabilities
- Long Term Debt
- Market Cap
- Net Income
- Net Income TTM
- Net PP&E
- Operating Earnings Yield Pro
- Operating Margin TTM Pro
- Operating PE Ratio Pro
- Other Comprehensive Income Pro
- PE 10 Pro
- PE Ratio
- PE Value Pro
- PEG Ratio
- PS Value Pro
- Payout Ratio TTM Pro
- Price
- Price / Book Value
- Price / Sales Ratio
- Price / Tangible Book Value Pro
- Profit Margin
- R&D Expense
- Receivables Turnover
- Retained Earnings
- Retained Earnings Growth
- Return on Assets
- Return on Equity
- Return on Invested Capital Pro
- Revenue Growth
- Revenue Per Share TTM
- Revenues
- Revenues TTM
- SG&A Expense
- Shareholders Equity
- Shares Outstanding
- Stock Buybacks
- Tangible Book Value Pro
- Tangible Book Value Per Share Pro
- Tangible Common Equity Ratio Pro
- Times Interest Earned TTM Pro
- Total Assets
- Total Return Price
- Valuation (Historical Mult.) Pro
- Valuation Percentage Pro
- Value Score Pro
Select a metric
Date range:
to
<Embed Chart>
Pro Save as Image
Pro Data Export
Copy the code below and paste
into the embed destination.
into the embed destination.
Attention
OK
ZGNX Market Cap Rankings
| Overall | 25th percentile | 3475 of 4665 |
| Sector | 33rd percentile | 349 of 527 in Healthcare |
| Industry | 25th percentile | 20 of 27 in Drug Manufacturers - Major |
ZGNX Market Cap Range, Past 5 Years
| Minimum | 62.37M | Sep 2011 |
| Maximum | 194.65M | Dec 2010 |
| Average | 136.66M |
About Market Capitalization
Market Capitalization (Market Cap) is a measurement of business value based on share price and number of shares outstanding. It generally represents the market's view of a company's stock value and is a determining factor in stock valuation.
For example, if a company has 1.5 million shares outstanding at a share price of $25, its market cap is $37.5 million (1.5 million x $25). Companies can be categorized based upon the size of their market capitalization.
There are five basic groups: mega-cap (market cap over $200B), large-cap ($10B–$200B), mid-cap ($2B–$10B), small-cap ($300M–$2B), and micro-cap ($50M-$300M). Market cap is not always an accurate indication of value because it does not account for debt and other factors.
Learn More
You may also be interested in these ZGNX related companies
ZGNX News
@SomeGuy900 ur bio says not to listen to u. sooooooo i wont. my skyrocket stock of the day for u is.....$MVIS +38.75% 2day but watch $ZGNX 2
about 10 hours ago by Bleedblue
about 10 hours ago by Bleedblue
$zgnx stocks on uptrends often have flat periods, i call it side movement, inbetween pops. In other words tomorrow will likely be a great.
about 13 hours ago by extrainnings
about 13 hours ago by extrainnings
@Bleedblue look at it like nobody is willing to sell $ZGNX cheap rather than nobody buys it.
about 19 hours ago by kami_ss
about 19 hours ago by kami_ss
@Bleedblue no worries, once $ZGNX starts running again everybody jumps in.
about 19 hours ago by kami_ss
about 19 hours ago by kami_ss
$ZGNX has trading been halted on this today or what? Flat as a pancake! got some maple syrup
about 19 hours ago by Bleedblue
about 19 hours ago by Bleedblue
$ZGNX Mentioned more than normal on StockTwits - Currently at 2 x average daily social activity
about 20 hours ago by TradeIdeasQuant
about 20 hours ago by TradeIdeasQuant
$zgnx soon as volume picks up should be another good bump up dont get scared yet.
about 21 hours ago by extrainnings
about 21 hours ago by extrainnings
Stocks with large upside potentials: (ORYN:OTCQB, US), $ZGNX, ($GNOM at ~2$)
about 23 hours ago by kami_ss
about 23 hours ago by kami_ss
@newkidontheblock hey bro u have the same portfo i do except i added $ZGNX yesterday. check this forecast out http://stks.co/42r4
about a day ago by Bleedblue
about a day ago by Bleedblue
@SlownSteady $DRRX down & $ZGNX up nicely today. Both connected by Risperidone. Is something antagonistic going on? http://stks.co/42aE
about a day ago by SciGuy
about a day ago by SciGuy
$ZGNX Mentioned more than normal on StockTwits - Currently at 3 x average daily social activity
about 2 days ago by TradeIdeasQuant
about 2 days ago by TradeIdeasQuant
Morning Movers 05/30: (BAH) (TFM) (DGIT) Higher; (PBY) (TEA) (SURG) (PWRD) (MAGS) Lower
May 30, 11:20AM Street Insider
May 30, 11:20AM Street Insider
$zgnx $ZGNX just saw nice blurb on briefing.com about the co. and nda for schizo drug, could be interesting soon. nice price as well
about 2 days ago by randal
about 2 days ago by randal
RT @Bleedblue @SciGuy let me known what u think about $ZGNX once u dig into it. <im reeeel close to divin in>
about 2 days ago by Bleedblue
about 2 days ago by Bleedblue
Zogenix Announces Conference Call and Webcast to Present First Quarter 2012 Financial Results
May 03, 7:30AM GlobeNewswire
May 03, 7:30AM GlobeNewswire
Zogenix (ZGNX), Battelle Finalize DosePro Licensing, Development Opportunities
Mar 29, 7:37AM Street Insider
Mar 29, 7:37AM Street Insider
Zogenix and Battelle Ink Marketing Agreement for DosePro Drug Delivery Technology
Mar 29, 7:31AM Benzinga
Mar 29, 7:31AM Benzinga
Zogenix and Battelle Ink Marketing Agreement for DosePro(R) Drug Delivery Technology
Mar 29, 7:30AM GlobeNewswire
Mar 29, 7:30AM GlobeNewswire
Zogenix, Inc. (ZGNX) Misses Q4 EPS by 2c; Guides FY12 Sales Well Below the Street
Mar 08, 4:13PM Street Insider
Mar 08, 4:13PM Street Insider
Zogenix Announces Conference Call and Webcast to Present Fourth Quarter and Full Year 2011 Financial Results
Feb 27, 4:05PM GlobeNewswire
Feb 27, 4:05PM GlobeNewswire
Recent Quotes
| Symbol | Price | Chg | Chg % | Market Cap |
|---|---|---|---|---|
| ZGNX | 1.80 | -0.04 | -2.17% | 117.67M |
| ZF | 2.97 | -0.01 | -0.34% | |
| ZEUS | 16.58 | -0.34 | -2.01% | 180.72M |
| ZEP | 14.02 | +0.07 | +0.50% | 307.74M |
| ZBRA | 33.47 | -0.33 | -0.98% | 1.744B |
| ZBB | 0.41 | +0.02 | +5.13% | 16.83M |
| WWE | 7.88 | +0.03 | +0.38% | 586.90M |
| WWD | 37.71 | -0.41 | -1.08% | 2.603B |
| WWAY | 5.72 | -0.20 | -3.38% | 74.30M |
| WVFC | 7.62 | -0.38 | -4.75% | 15.70M |